Growth Failure
Drug | Drug Name | Drug Description |
---|---|---|
DB16220 | Lonapegsomatropin | A human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion. |
DB14751 | Mecasermin rinfabate | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... |
DB00052 | Somatotropin | A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults. |
DB14960 | Somatrogon | A long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00936 | Salicylic acid | 1 | Completed | 1 |
DB00052 | Somatotropin | 1 | Completed | 1 |
DB01277 | Mecasermin | 1 / 2 | Terminated | 1 |
DB00052 | Somatotropin | 3 | Recruiting | 1 |
DB00125 | Arginine | 4 | Unknown Status | 1 |
DB00575 | Clonidine | 4 | Unknown Status | 1 |
DB13956 | Estradiol valerate | 4 | Unknown Status | 1 |
DB00052 | Somatotropin | 4 | Unknown Status | 1 |
DB13961 | Fish oil | Not Available | Available | 1 |
DB01277 | Mecasermin | Not Available | Withdrawn | 1 |
DB13959 | Medium-chain triglycerides | Not Available | Available | 1 |
DB09567 | Olive oil | Not Available | Available | 1 |
DB09422 | Soybean oil | Not Available | Available | 1 |